Hepatitis C virus NS3 protease is activated by low concentrations of protease inhibitors.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Biochemistry

• Publication date

  2009-12-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/bi9016928PMID 19839643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.

  2009cited by this paper
• Binding of a noncovalent inhibitor exploiting the S' region stabilizes the hepatitis C virus NS3 protease conformation in the absence of cofactor.

  2009cited by this paper
• Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).

  2008cited by this paper
• Substrate‐dependent hysteretic behavior in StEH1‐catalyzed hydrolysis of styrene oxide derivatives

  2008cited by this paper
• Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase*S⃞

  2008cited by this paper
• Hepatitis C Virus NS3 Helicase Forms Oligomeric Structures That Exhibit Optimal DNA Unwinding Activity in Vitro*

  2008cited by this paper
• Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex

  2008cited by this paper
• New developments in the discovery of agents to treat hepatitis C.

  2008cited by this paper
• Beta-amino acid substitutions and structure-based CoMFA modeling of hepatitis C virus NS3 protease inhibitors.

  2008cited by this paper
• RNA unwinding activity of the hepatitis C virus NS3 helicase is modulated by the NS5B polymerase.

  2008cited by this paper
• The Serine Protease Domain of Hepatitis C Viral NS3 Activates RNA Helicase Activity by Promoting the Binding of RNA Substrate*

  2007cited by this paper
• Resistance Profiling of Hepatitis C Virus Protease Inhibitors using Full-Length NS3

  2007cited by this paper
• Replication of hepatitis C virus

  2007cited by this paper
• Mechanistic studies of electrophilic protease inhibitors of full length hepatic C virus (HCV) NS3

  2007cited by this paper
• Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors.

  2007cited by this paper
• Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3

  2007cited by this paper
• Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3.

  2006cited by this paper
• Stimulation of Hepatitis C Virus (HCV) Nonstructural Protein 3 (NS3) Helicase Activity by the NS3 Protease Domain and by HCV RNA-Dependent RNA Polymerase

  2005cited by this paper
• The RNA-unwinding activity of hepatitis C virus non-structural protein 3 (NS3) is positively modulated by its protease domain.

  2005cited by this paper
• In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061

  2004cited by this paper
• Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.

  2004cited by this paper
• Damped oscillatory hysteretic behaviour of butyrylcholinesterase with benzoylcholine as substrate.

  2003cited by this paper
• Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals.

  2003cited by this paper
• Expression and purification of recombinant full-length NS3 protease-helicase from a new variant of Hepatitis C virus.

  2002cited by this paper
• Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase).

  2002cited by this paper
• Effect of naturally occurring active site mutations on hepatitis C virus NS3 protease specificity

  2001cited by this paper
• Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain.

  2001cited by this paper
• Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain

  2000cited by this paper
• The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism.

  1999cited by this paper
• Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptide.

  1999cited by this paper
• Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction.

  1999cited by this paper
• The Helicase from Hepatitis C Virus Is Active as an Oligomer*

  1999cited by this paper
• Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.

  1999cited by this paper
• Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.

  1999cited by this paper
• Multiple Enzymatic Activities Associated with Recombinant NS3 Protein of Hepatitis C Virus

  1998cited by this paper
• Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.

  1998cited by this paper
• Construction, expression, and characterization of a novel fully activated recombinant single‐chain hepatitis C virus protease

  1998cited by this paper
• Rational design and functional expression of a constitutively active single-chain NS4A-NS3 proteinase.

  1998cited by this paper
• Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide.

  1997cited by this paper
• Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.

  1997cited by this paper
• A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates.

  1996cited by this paper
• Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

  1996cited by this paper
• Enzymes as biosensors. 2. Hysteretic response of chloroplastic fructose-1,6-bisphosphatase to fructose 2,6-bisphosphate.

  1988cited by this paper
• Mnemonic aspects of Escherichia coli DNA polymerase I. Interaction with one template influences the next interaction with another template.

  1986cited by this paper
• Regulatory behavior of monomeric enzymes. 1. The mnemonical enzyme concept.

  1974cited by this paper
• Regulatory behavior of monomeric enzymes. 2. A wheat-germ hexokinase as a mnemonical enzyme.

  1974cited by this paper
• Co-operative effects in enzyme catalysis: a possible kinetic model based on substrate-induced conformation isomerization.

  1967cited by this paper

• The zymogenic form of SARS-CoV-2 main protease: A discrete target for drug discovery

  2024cites this paper
• Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA – effects on NS5B catalysis and allosteric inhibition

  2017cites this paper
• Accounting for strain variations and resistance mutations in the characterization of hepatitis C NS3 protease inhibitors

  2014cites this paper
• Identification of weak points of hepatitis C virus NS3 protease inhibitors using surface plasmon resonance biosensor-based interaction kinetic analysis and genetic variants.

  2014cites this paper
• Chapter 688 – Hepacivirin

  2013cites this paper
• Hepatitis C Virus Non-Structural Protein 3/4A: A Tale of Two Domains: A Dissertation

  2012cites this paper
• Novel Peptide Mimetics Based on N-protected Amino Acids Derived from Isomannide as Potential Inhibitors of NS3 Serine Protease of Hepatitis C Virus

  2012cites this paper
• Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors

  2011cites this paper
• Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease

  2011cites this paper
• Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335*

  2011cites this paper
• Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

  2010cites this paper